Public Company News
Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration
MELBOURNE, Australia and PALO ALTO, Calif., Dec. 11, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces a strategic clinical collaboration with Varian, a Siemens Healthineers company and global leader in radiation oncology, to develop novel clinica...
2025-12-11 03:30
2209
SINBON Expansion as Green Solutions Provider Aimed at Transforming Electronics into Conduits of Sustainability
TAIPEI, Dec. 10, 2025 /PRNewswire/ -- SINBON Electronics Co., Ltd.
2025-12-11 01:00
2428
NYSE Content Advisory: Pre-Market Update + Magnum is World's Largest Ice Cream Business after Spinoff
NEW YORK, Dec. 10, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content Advisory: Pre-Market Update + Magnum is World's Lar...
2025-12-10 22:01
3367
DXC Launches AdvisoryX and Releases New Global Insights on the AI Execution Gap
ASHBURN, Va., Dec. 10, 2025 /PRNewswire/ -- DXC Technology (NYSE: DXC), a leading enterprise technology and innovation partner, today announced the launch of AdvisoryX, a global advisory and consulting group designed to help enterprises address their most complex strategic, operational, and techn...
2025-12-10 22:00
2235
AAR and Air France Industries KLM Engineering & Maintenance complete formation of xCelle Asia joint venture
WOOD DALE, Ill. and PARIS and AMSTELVEEN, Netherlands and CHONBURI, Thailand, Dec. 10, 2025 /PRNewswire/ -- AAR CORP. (NYSE: AIR), a leading provider of aviation services to commercial and government operators, MROs, and OEMs, and Air France Industries KLM Engineering & Maintenance (AFI KLM E&M),...
2025-12-10 21:18
1987
SPARE CAPACITY PERSISTS GLOBALLY, WHILE NORTH AMERICA REPORTS A STEEPER PULLBACK IN MANUFACTURING DEMAND, SIGNALLING WEAK CONDITIONS HEADING INTO 2026: GEP GLOBAL SUPPLY CHAIN VOLATILITY INDEX
* North America posts the steepest decline in input demand by region, signaling softening activity heading into 2026 * Europe and the UK remain subdued amid weak manufacturing pipelines * Asia sees another month of low demand as Chinese factory purchasing continues to slow * With ample spa...
2025-12-10 21:17
3206
Kazia Therapeutics Highlights New Clinical and Translational Findings Demonstrating Paxalisib's Ability to Reinvigorate Anti-Tumor Immunity Across Multiple Advanced Breast Cancer Populations including TNBC and HER2+
First patient from TNBC trial demonstrated 76% tumor volume shrinkage with corresponding reductions in circulating tumor cells (CTC) and clusters Reinvigoration of immune system + turning cold tumors hot Preliminary ex-vivo data in HER2+ patients demonstrates immune reinvigoration and reductions...
2025-12-10 21:00
6009
NaaS Technology Inc. Regains Compliance with Nasdaq Minimum Market Value of Listed Securities Requirement
BEIJING, Dec. 10, 2025 /PRNewswire/ -- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"), the first U.S.-listed EV charging service company in China, today announced that on December 9, 2025, it received written notice from the Listing Qualifications Department (the "Staff") of Nasdaq...
2025-12-10 20:00
2986
CNFINANCE ANNOUNCES THE RESULTS OF ITS EXTRAORDINARY GENERAL MEETING
GUANGZHOU, China, Dec. 10, 2025 /PRNewswire/ -- CNFinance Holdings Limited (NYSE: CNF) ("CNFinance" or the "Company"), a leading home equity loan service provider inChina, today announced the results of its extraordinary general meeting of shareholders held at 22nd Floor, South Finance Building, ...
2025-12-10 19:15
2604
World Gym Corporation (2762.TW) Reports Robust November Revenue Growth and Unveils Ambitious 2026 Strategic Roadmap
TAIPEI, Dec. 10, 2025 /PRNewswire/ -- World Gym Corp. (2762.TW), owner and operator of the iconic World Gym brand, announced consolidated revenue of NT$959,696 thousand for November 2025, representing a robust year-over-year increase of 14.24% compared toNovember 2024. YTD Revenue surpassed the NT...
2025-12-10 18:30
2124
Admission To Trading on The London Stock Exchange and Completion of Secondary Listing
PARIS, NEW YORK, and LONDON, Dec. 10, 2025 /PRNewswire/ -- The Generation Essentials Group ("TGE" or the "Company", NYSE and LSE: TGE) refers to its announcement published onDecember 5, 2025 relating to the approval by the UK Financial Conduct Authority (the "FCA") of a prospectus for its propose...
2025-12-10 18:27
2639
Ascletis Announces China National Medical Products Administration Acceptance of New Drug Application for Denifanstat (ASC40), a First-in-Class FASN Inhibitor for Acne Treatment
-Denifanstat (ASC40) met all primary, key secondary and secondary efficacy endpoints (ITT analysis) and significantly improved moderate-to-severe acne vulgaris compared with placebo in a randomized, double-blind, placebo-controlled, multicenter Phase III clinical trial. HONG KONG, Dec. 10, 2025 ...
2025-12-10 17:15
3289
An Income Strategy for Volatile Markets - CSOP HSCEI Covered Call Active ETF (2802.HK) Debuts on HKEX Tomorrow
HONG KONG, Dec. 10, 2025 /PRNewswire/ -- CSOP HSCEI Covered Call Active ETF (2802.HK) will be listed on the Hong Kong Stock Exchange on11 December 2025. 2802.HK seeks to achieve its investment objective by primarily (i) investing in constituent equity securities in the Hang Seng China Enterprises...
2025-12-10 16:28
5505
Kia unveils the all-new Seltos: a bold SUV with a strong presence and maximized user experience
* The all-new Kia Seltos makes its global debut through an online world premiere themed 'The Protagonist' * Redesigned with authentic SUV styling and practical functionality * Strengthens Kia's SUV lineup, reaffirming its role as a key global model * Empowers users to discover their true se...
2025-12-10 15:15
1654
Stay True to Our Original Aspiration, Forge Ahead into the Future｜Alphamab Oncology 2025 R&D Day Successfully Held
SUZHOU, China, Dec. 10, 2025 /PRNewswire/ -- On December 8, 2025, Alphamab Oncology (Stock Code: 9966.HK) successfully held its "Stay True to Our Original Aspiration, Forge Ahead into the Future" 2025 R&D Day inShanghai. The event focused on the latest advancements in the field of antibody-drug c...
2025-12-10 14:20
2396
iQIYI Scream Night 2025 Spotlights Creative Excellence and Industry Momentum
iQIYI and Galaxy Arena renew three-year strategic partnership to boost entertainment and tourism BEIJING, Dec. 10, 2025 /PRNewswire/ -- On December 6, iQIYI, China's leading online entertainment platform, hosted its annual Scream Night at the Galaxy Arena inMacao, presenting 63 honors across six...
2025-12-10 12:40
7503
IIJ Launches Enhanced Safous Security Assessment With Expanded Attack Surface Monitoring and New Support Capabilities
* Enhanced service delivers continuous external attack surface visibility and more precise threat monitoring. * Annual subscribers receive monthly risk assessment reports, real-time alerts, and access to a dedicated support portal. * Optional analyst-led consulting provides prioritized risk ...
2025-12-10 12:00
2106
Supermicro Expands NVIDIA Blackwell Portfolio with New 4U and 2-OU (OCP) Liquid-Cooled NVIDIA HGX B300 Solutions Ready for High-Volume Shipment
* Introducing 4U and 2-OU (OCP) liquid-cooled NVIDIA HGX B300 systems for high-density hyperscale and AI factory deployments, supported by Supermicro Data Center Building Block Solutions® with DLC-2 and DLC technology, respectively * 4U liquid-cooled NVIDIA HGX B300 systems designed for stand...
2025-12-10 10:20
2352
Innovent Announces First Participant Dosed in a Phase 1 Clinical Trial of IBI3011, a Recombinant Anti-Human Interleukin 1 Receptor Accessory Protein Monoclonal Antibody
SAN FRANCISCO and SUZHOU, China, Dec. 9, 2025 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ...
2025-12-10 08:26
2171
Lee's Pharmaceutical Holdings Limited Acquires Staccato® One Breath Technology® Platform and Assets, Driving Pipeline Expansion and Advancing Global Partnership with UCB Through Acquired Rights
* Acquisition of Staccato® One Breath Technology®, a proprietary platform technology with broad therapeutic potential * Synergistic and complementary to Lee's Pharm's existing products pipeline, and * Acquisition of rights as licensor and manufacturer of Staccato® alprazolam under a global ...
2025-12-10 08:00
3136
Week's Top Stories
Most Reposted
Visa Working Capital Index: Asia Pacific CFOs Call for Flexible, Digital Finance Solutions
[Picked up by 308 media titles]
2026-03-24 14:00HOY Unveils a Powerhouse Line-up of Talent for its Bold New Chapter
[Picked up by 306 media titles]
2026-03-20 09:36
MetaOptics progresses on its strategic growth and leadership transition initiatives
[Picked up by 283 media titles]
2026-03-20 08:15ART CENTRAL COMMENCES DISCOVERY-LED ELEVENTH EDITION
[Picked up by 277 media titles]
2026-03-25 16:51
Allianz Partners Australia's 2025 State of Student Healthcare Report Unpacks the Complex Realities of International Students
[Picked up by 275 media titles]
2026-03-19 09:00Most Read
Everbright Environment Announces 2025 Annual Results
2026-03-20 23:14
7658
Ten Pao Group Announces 2025 Annual Results
2026-03-20 23:35
7455
FiEE, Inc. Announces Fourth Quarter and Full-Year 2025 Financial Results
2026-03-21 04:05
7420
U Power Limited Announces Closing of $6.0 Million Public Offering
2026-03-21 02:40
6960